Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
Lumos Pharma
Lumos Pharma
National Institutes of Health Clinical Center (CC)
Sumitomo Pharma America, Inc.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Quest PharmaTech Inc.
Acrotech Biopharma Inc.
M.D. Anderson Cancer Center
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Pfizer
National Institutes of Health Clinical Center (CC)